Is raloxifene therapy in postmenopausal women associated with a significant reduction in the concentration of serum vascular endothelial growth factor?
Raloxifene therapy in postmenopausal women is associated with a significant reduction in serum VEGF concentration.
Increased macrophage PON2 expression under oxidative stress could represent a selective cellular response to reduce oxidative burden, which may lead to attenuation of macrophage foam cell formation.